When pharmaceutical teams investigate nitrosamine risk, attention often begins with the active pharmaceutical ingredient (API) and its manufacturing process. But the API is only part of the picture. Excipients can contribute to nitrosamine risk by introducing trace nitrite or other relevant precursors into a drug product. When those precursors encounter a susceptible amine under favorable […]